Free Trial
NASDAQ:SNPX

Synaptogenix (SNPX) Stock Price, News & Analysis

Synaptogenix logo
$2.96 +0.12 (+4.19%)
Closing price 02/21/2025 03:58 PM Eastern
Extended Trading
$2.96 +0.00 (+0.03%)
As of 02/21/2025 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Synaptogenix Stock (NASDAQ:SNPX)

Key Stats

Today's Range
$2.87
$2.99
50-Day Range
$2.57
$3.90
52-Week Range
$2.32
$6.22
Volume
5,799 shs
Average Volume
7,261 shs
Market Capitalization
$4.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

Synaptogenix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

SNPX MarketRank™: 

Synaptogenix scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Synaptogenix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Synaptogenix has received no research coverage in the past 90 days.

  • Read more about Synaptogenix's stock forecast and price target.
  • Percentage of Shares Shorted

    1.91% of the float of Synaptogenix has been sold short.
  • Short Interest Ratio / Days to Cover

    Synaptogenix has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Synaptogenix has recently decreased by 2.68%, indicating that investor sentiment is improving.
  • Dividend Yield

    Synaptogenix does not currently pay a dividend.

  • Dividend Growth

    Synaptogenix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.91% of the float of Synaptogenix has been sold short.
  • Short Interest Ratio / Days to Cover

    Synaptogenix has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Synaptogenix has recently decreased by 2.68%, indicating that investor sentiment is improving.
  • Search Interest

    1 people have searched for SNPX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Synaptogenix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.73% of the stock of Synaptogenix is held by insiders.

  • Percentage Held by Institutions

    Only 10.34% of the stock of Synaptogenix is held by institutions.

  • Read more about Synaptogenix's insider trading history.
Receive SNPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter.

SNPX Stock News Headlines

Synaptogenix Inc Ordinary Shares
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
Synaptogenix Announces $5.0 Million Financing
See More Headlines

SNPX Stock Analysis - Frequently Asked Questions

Synaptogenix's stock was trading at $3.47 on January 1st, 2025. Since then, SNPX shares have decreased by 14.7% and is now trading at $2.9590.
View the best growth stocks for 2025 here
.

Synaptogenix, Inc. (NASDAQ:SNPX) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($4.58) earnings per share for the quarter, missing analysts' consensus estimates of ($1.95) by $2.63.

Synaptogenix shares reverse split before market open on Friday, April 5th 2024. The 1-25 reverse split was announced on Friday, April 5th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Synaptogenix's top institutional shareholders include Geode Capital Management LLC (0.80%). Insiders that own company stock include Daniel L Alkon and William S Singer.
View institutional ownership trends
.

Shares of SNPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synaptogenix investors own include SoFi Technologies (SOFI), Fluence Energy (FLNC), The9 (NCTY), Riot Platforms (RIOT), PubMatic (PUBM), Clean Energy Fuels (CLNE) and FuelCell Energy (FCEL).

Company Calendar

Last Earnings
11/12/2024
Today
2/22/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SNPX
Fax
N/A
Employees
4
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$14.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+373.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-6,040,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$25.27 per share

Miscellaneous

Free Float
1,319,000
Market Cap
$4.02 million
Optionable
Not Optionable
Beta
1.07
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SNPX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners